Read + Share
Amedeo Smart
Independent Medical Education
Moghavem N, Henderson VW, Greicius MD. Medicare should not cover aducanumab as a treatment for Alzheimer's disease. Ann Neurol 2021 Jul 19. doi: 10.1002/ana.26167.PMID: 34278596
Email
LinkedIn
Facebook
Twitter
Privacy Policy